Someone should tell Provista shareholders that their thriving company is about to be a subsidiary of Radient Pharmaceuticals as described in the 2010 LOI.
Then show them the last 10-K that Radient filed, for 2011.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.